The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
The genetics of multiple sclerosis: an up‐to‐date review
Open accessAbstract
Summary: Multiple sclerosis (MS) is a prevalent inflammatory disease of the central nervous system that often leads to disability in young adults. Treatment options are limited and often only partly effective. The disease is likely caused by a complex interaction between multiple genes and environmental factors, leading to inflammatory‐mediated central nervous system deterioration. A series of genomic studies have confirmed a central role for the immune system in the development of MS, including genetic association studies that have now dramatically expanded the roster of MS susceptibility genes beyond the longstanding human leukocyte antigen (HLA) association in MS first identified nearly 40 years ago. Advances in technology together with novel models for collaboration across research groups have enabled the discovery of more than 50 non‐HLA genetic risk factors associated with MS. However, with a large proportion of the disease heritability still unaccounted for, current studies are now geared towards identification of causal alleles, associated pathways, epigenetic mechanisms, and gene–environment interactions. This article reviews recent efforts in addressing the genetics of MS and the challenges posed by an ever increasing amount of analyzable data, which is spearheading development of novel statistical methods necessary to cope with such complexity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903 · cited 1×
“novel ways with unparalleled flexibility (120).”
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034 · cited 1×
“Systems biology aims to increase understanding of biological and medical problems from a holistic perspective by considering all processes involved and their dynamics (117, 118).”
BackgroundGoh, K.-I., Cusick, M. E., Valle, D., Childs, B., Vidal, M., & Barabási, A.-L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701361104 · Cited by 3,242
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697 · cited 7×
“This latest screen identified 52 MS risk loci with genomewide significance (Table 1), of which 29 were novel (6).”
BackgroundMethodInfluentialA polymorphic DNA marker genetically linked to Huntington's disease
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,347
Harrison’s Principles of Internal Medicine
Malani, P. N. (2012) · JAMA · doi:10.1001/jama.308.17.1813-b · Cited by 2,039
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746 · cited 1×
“Indeed, in 2007 the first MS GWAS identified the first non-HLA regions with genome-wide significance (P < 10) using a two-step approach (18).”
MethodAssociation scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Wellcome Trust Case Control Consortium, & The Australo-Anglo-American Spondylitis Consortium (TASC) (2007) · Nature Genetics · doi:10.1038/ng.2007.17 · Cited by 1,374
On the allelic spectrum of human disease
Reich, D. E., & Lander, E. S. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02410-6 · Cited by 1,185
Predictive, personalized, preventive, participatory (P4) cancer medicine
Hood, L., & Friend, S. H. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.227 · Cited by 900
Ramagopalan, S. V., Heger, A., Berlanga, A. J., Maugeri, N. J., Lincoln, M. R., Burrell, A., Handunnetthi, L., Handel, A. E., Disanto, G., Orton, S.-M., et al. (2010) · Genome Research · doi:10.1101/gr.107920.110 · Cited by 873
Ideker, T., & Sharan, R. (2008) · Genome Research · doi:10.1101/gr.071852.107 · Cited by 817
International MS Genetics Consortium, De Jager, P. L., Jia, X., Wang, J., de Bakker, P. I. W., Ottoboni, L., Aggarwal, N. T., Piccio, L., Raychaudhuri, S., Tran, D., et al. (2009) · Nature Genetics · doi:10.1038/ng.401 · Cited by 800
Self-citationIoannidis, J. P. A. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.081086 · Cited by 716 · cited 1×
“This may reflect a bias in statistical analysis or a lack of available data, but it may also indicate difficulties in performing clinical validation studies (115, 116).”
A full genome search in multiple sclerosis
Ebers, G. C., Kukay, K., Bulman, D. E., Sadovnick, A. D., Rice, G., Anderson, C., Armstrong, H., Cousin, K., Bell, R. B., Hader, W., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-472 · Cited by 659
for the Multiple Sclerosis Genetics Group, Gregory, S. G., Schmidt, S., Seth, P., Oksenberg, J. R., Hart, J., Prokop, A., Caillier, S. J., Ban, M., Goris, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2103 · Cited by 657
Self-citationHaines, J. L., Ter-Minassian, M., Bazyk, A., Gusella, J. F., Kim, D. J., Terwedow, H., PericakVance, M. A., Rimmler, J. B., Haynes, C. S., Roses, A. D., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-469 · Cited by 651
Self-citationA genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
Sawcer, S., Jones, H. B., Feakes, R., Gray, J., Smaldon, N., Chataway, J., Robertson, N., Clayton, D., Goodfellow, P. N., & Compston, A. (1996) · Nature Genetics · doi:10.1038/ng0896-464 · Cited by 643
Pervasive Sharing of Genetic Effects in Autoimmune Disease
Cotsapas, C., Voight, B. F., Rossin, E., Lage, K., Neale, B. M., Wallace, C., Abecasis, G. R., Barrett, J. C., Behrens, T., Cho, J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002254 · Cited by 606
Bielekova, B., Catalfamo, M., Reichert-Scrivner, S., Packer, A., Cerna, M., Waldmann, T. A., McFarland, H., Henkart, P. A., & Martin, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601335103 · Cited by 597
Detecting shared pathogenesis from the shared genetics of immune-related diseases
Zhernakova, A., van Diemen, C. C., & Wijmenga, C. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2489 · Cited by 551 · cited 1×
“For example, identification of genetic similarities among complex diseases, particularly autoimmune diseases, is a topic of intense research (32, 125, 126).”
BackgroundThe Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) (2009) · Nature Genetics · doi:10.1038/ng.396 · Cited by 550
Ramagopalan, S. V., Maugeri, N. J., Handunnetthi, L., Lincoln, M. R., Orton, S.-M., Dyment, D. A., DeLuca, G. C., Herrera, B. M., Chao, M. J., Sadovnick, A. D., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000369 · Cited by 519
HLA class II‐associated genetic susceptibility in multiple sclerosis: A critical evaluation
Olerup, O., & Hillert, J. (1991) · Tissue Antigens · doi:10.1111/j.1399-0039.1991.tb02029.x · Cited by 490
Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis
Lundmark, F., Duvefelt, K., Iacobaeus, E., Kockum, I., Wallström, E., Khademi, M., Oturai, A., Ryder, L. P., Saarela, J., Harbo, H. F., et al. (2007) · Nature Genetics · doi:10.1038/ng2106 · Cited by 483 · cited 1×
“Simultaneously, the IL7Ra gene was confirmed to be associated in other MS cohorts (19, 20).”
BackgroundSelf-citationGenome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis
Baranzini, S. E., Mudge, J., van Velkinburgh, J. C., Khankhanian, P., Khrebtukova, I., Miller, N. A., Zhang, L., Farmer, A. D., Bell, C. J., Kim, R. W., et al. (2010) · Nature · doi:10.1038/nature08990 · Cited by 476 · cited 1×
“Although next generation sequencing has been applied before to the study of MS genomes (36), the work described above is the first report that identifies mutations likely involved in MS pathogenesis.”
MethodSelf-citationGenome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
Baranzini, S. E., Wang, J., Gibson, R. A., Galwey, N., Naegelin, Y., Barkhof, F., Radue, E.-W., Lindberg, R. L. P., Uitdehaag, B. M. G., Johnson, M. R., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn388 · Cited by 476
Self-citationHISTOCOMPATIBILITY DETERMINANTS IN MULTIPLE SCLEROSIS, WITH SPECIAL REFERENCE TO CLINICAL COURSE
Jersild, C., Hansen, G., Svejgaard, A., Fog, T., Thomsen, M., & Dupont, B. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90970-7 · Cited by 469
Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
Ma, Q., & Lu, A. Y. H. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003533 · Cited by 464
McDevitt, H. O., & Chinitz, A. (1969) · Science · doi:10.1126/science.163.3872.1207 · Cited by 418
A CD8+ T cell transcription signature predicts prognosis in autoimmune disease
McKinney, E. F., Lyons, P. A., Carr, E. J., Hollis, J. L., Jayne, D. R. W., Willcocks, L. C., Koukoulaki, M., Brazma, A., Jovanovic, V., Kemeny, D. M., et al. (2010) · Nature Medicine · doi:10.1038/nm.2130 · Cited by 370
(1964) · The Lancet · doi:10.1016/s0140-6736(64)91052-9 · Cited by 366
Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci
Patsopoulos, N. A., the Bayer Pharma MS Genetics Working Group, T. S. C. O. S. E. I. A. A. C., & de Bakker, P. I. W. (2011) · Annals of Neurology · doi:10.1002/ana.22609 · Cited by 353
Mapping Multiple Sclerosis Susceptibility to the HLA-DR Locus in African Americans
Oksenberg, J. R., Barcellos, L. F., Cree, B. A. C., Baranzini, S. E., Bugawan, T. L., Khan, O., Lincoln, R. R., Swerdlin, A., Mignot, E., Lin, L., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/380997 · Cited by 340
Self-citationHL-A ANTIGENS AND MULTIPLE SCLEROSIS
Jersild, C., Svejgaard, A., & Fog, T. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90962-2 · Cited by 324
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis
Barcellos, L. F., Sawcer, S., Ramsay, P. P., Baranzini, S. E., Thomson, G., Briggs, F., Cree, B. C. A., Begovich, A. B., Villoslada, P., Montalban, X., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl223 · Cited by 317
Self-citationMultiple Sclerosis: Association with HL—A3
NAITO, S., NAMEROW, N., MICKEY, M. R., & TERASAKI, P. I. (1972) · Tissue Antigens · doi:10.1111/j.1399-0039.1972.tb00111.x · Cited by 308
A High-Density Screen for Linkage in Multiple Sclerosis
(2005) · The American Journal of Human Genetics · doi:10.1086/444547 · Cited by 297
Fogdell‐Hahn, A., Ligers, A., Grønning, M., Hillert, J., & Olerup, O. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550205.x · Cited by 295
Cigarette Smoking and Incidence of Multiple Sclerosis
Hernan, M. A. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.1.69 · Cited by 292
A network view of disease and compound screening
Schadt, E. E., Friend, S. H., & Shaywitz, D. A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2826 · Cited by 291
Invited anniversary review: HLA associated diseases
Thorsby, E. (1997) · Human Immunology · doi:10.1016/s0198-8859(97)00024-4 · Cited by 272
Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis
Hedström, A. K., Sundqvist, E., Bäärnhielm, M., Nordin, N., Hillert, J., Kockum, I., Olsson, T., & Alfredsson, L. (2011) · Brain · doi:10.1093/brain/awq371 · Cited by 271
Smoking is a risk factor for multiple sclerosis
Riise, T., Nortvedt, M. W., & Ascherio, A. (2003) · Neurology · doi:10.1212/01.wnl.0000081305.66687.d2 · Cited by 250
Jakkula, E., Leppä, V., Sulonen, A.-M., Varilo, T., Kallio, S., Kemppinen, A., Purcell, S., Koivisto, K., Tienari, P., Sumelahti, M.-L., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.01.017 · Cited by 245
Self-citationMaier, L. M., Lowe, C. E., Cooper, J., Downes, K., Anderson, D. E., Severson, C., Clark, P. M., Healy, B., Walker, N., Aubin, C., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000322 · Cited by 245
Self-citationRare variants in the CYP27B1 gene are associated with multiple sclerosis
Ramagopalan, S. V., Dyment, D. A., Cader, M. Z., Morrison, K. M., Disanto, G., Morahan, J. M., Berlanga‐Taylor, A. J., Handel, A., De Luca, G. C., Sadovnick, A. D., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22678 · Cited by 229
Kuokkanen, S., Sundvall, M., Terwilliger, J. D., Tienari, P. J., Wikström, J., Holmdahl, R., Pettersson, U., & Peltonen, L. (1996) · Nature Genetics · doi:10.1038/ng0896-477 · Cited by 208
HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis
Brynedal, B., Duvefelt, K., Jonasdottir, G., Roos, I. M., Åkesson, E., Palmgren, J., & Hillert, J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000664 · Cited by 207
Wandinger, K.-P., Lünemann, J. D., Wengert, O., Bellmann-Strobl, J., Aktas, O., Weber, A., Grundström, E., Ehrlich, S., Wernecke, K.-D., Volk, H.-D., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13641-0 · Cited by 207
Functional epistasis on a common MHC haplotype associated with multiple sclerosis
Gregersen, J. W., Kranc, K. R., Ke, X., Svendsen, P., Madsen, L. S., Thomsen, A. R., Cardon, L. R., Bell, J. I., & Fugger, L. (2006) · Nature · doi:10.1038/nature05133 · Cited by 205
Moving toward a system genetics view of disease
Sieberts, S. K., & Schadt, E. E. (2007) · Mammalian Genome · doi:10.1007/s00335-007-9040-6 · Cited by 194
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis
Sanna, S., Pitzalis, M., Zoledziewska, M., Zara, I., Sidore, C., Murru, R., Whalen, M. B., Busonero, F., Maschio, A., Costa, G., et al. (2010) · Nature Genetics · doi:10.1038/ng.584 · Cited by 187
Marrosu, M. G., Murru, R., Murru, M. R., Costa, G., Zavattari, P., Whalen, M., Cocco, E., Mancosu, C., Schirru, L., Solla, E., et al. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2907 · Cited by 180
Wandinger, K., Stürzebecher, C., Bielekova, B., Detore, G., Rosenwald, A., Staudt, L. M., McFarland, H. F., & Martin, R. (2001) · Annals of Neurology · doi:10.1002/ana.1096 · Cited by 177
A second major histocompatibility complex susceptibility locus for multiple sclerosis
Yeo, T. W., De Jager, P. L., Gregory, S. G., Barcellos, L. F., Walton, A., Goris, A., Fenoglio, C., Ban, M., Taylor, C. J., Goodman, R. S., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21063 · Cited by 175
Self-citationGenetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis
Mkhikian, H., Grigorian, A., Li, C. F., Chen, H.-L., Newton, B., Zhou, R. W., Beeton, C., Torossian, S., Tatarian, G. G., Lee, S.-U., et al. (2011) · Nature Communications · doi:10.1038/ncomms1333 · Cited by 174
Okuda, D. T., Srinivasan, R., Oksenberg, J. R., Goodin, D. S., Baranzini, S. E., Beheshtian, A., Waubant, E., Zamvil, S. S., Leppert, D., Qualley, P., et al. (2009) · Brain · doi:10.1093/brain/awn301 · Cited by 174
Self-citationPredictive, preventive, personalized and participatory medicine: back to the future
Auffray, C., Charron, D., & Hood, L. (2010) · Genome Medicine · doi:10.1186/gm178 · Cited by 174
Harbo, H. F., Lie, B. A., Sawcer, S. J., Celius, E. G., Dai, K., Oturai, A. B., Hillert, J. A., Lorentzen, Å. R., Laaksonen, M., Myhr, K. M., et al. (2004) · Tissue Antigens · doi:10.1111/j.0001-2815.2004.00173.x · Cited by 170
Self-citationTranscription-Based Prediction of Response to IFNβ Using Supervised Computational Methods
Baranzini, S. E., Mousavi, P., Rio, J., Caillier, S. J., Stillman, A., Villoslada, P., Wyatt, M. M., Comabella, M., Greller, L. D., Somogyi, R., et al. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0030002 · Cited by 169
Self-citationEpistasis among HLA-DRB1, HLA-DQA1,and HLA-DQB1 loci determines multiple sclerosis susceptibility
Lincoln, M. R., Ramagopalan, S. V., Chao, M. J., Herrera, B. M., DeLuca, G. C., Orton, S.-M., Dyment, D. A., Sadovnick, A. D., & Ebers, G. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812664106 · Cited by 169
Stürzebecher, S., Wandinger, K. P., Rosenwald, A., Sathyamoorthy, M., Tzou, A., Mattar, P., Frank, J. A., Staudt, L., Martin, R., & McFarland, H. F. (2003) · Brain · doi:10.1093/brain/awg147 · Cited by 168
HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis
Hensiek, A. E. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.184 · Cited by 167
The genetics of autoimmune diseases: a networked perspective
Baranzini, S. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.09.014 · Cited by 160
Self-citationSmoking is a risk factor for multiple sclerosis: a metanalysis
Hawkes, C. H. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506073501 · Cited by 149
DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population
Marrosu, M. G., Murru, M. R., Costa, G., Murru, R., Muntoni, F., & Cucca, F. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.8.1235 · Cited by 146
Marrosu, M. G., Murru, M. R., Costa, G., Cucca, F., Sotgiu, S., Rosati, G., & Muntoni, F. (1997) · The American Journal of Human Genetics · doi:10.1016/s0002-9297(07)64074-9 · Cited by 145
Uncoupling the Roles of HLA-DRB1 and HLA-DRB5 Genes in Multiple Sclerosis
Caillier, S. J., Briggs, F. B. S., Cree, B., Baranzini, S. E., Fernández-Viña, M., Ramsay, P. P., Khan, O. A., Royal, W., Hauser, S. L., Barcellos, L. F., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5473 · Cited by 140
Self-citationB-LYMPHOCYTE ALLOANTIGENS ASSOCIATED WITH MULTIPLE SCLEROSIS
Compston, D. A. S. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92027-4 · Cited by 128
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility
Couturier, N., Bucciarelli, F., Nurtdinov, R., Debouverie, M., Lebrun‐Frénay, C., Defer, G. L., Moreau, T., Confavreux, C., Vukusic, S., Cournu‐Rebeix, I., et al. (2011) · Brain · doi:10.1093/brain/awr010 · Cited by 126
Corvol, J., Pelletier, D., Henry, R. G., Caillier, S. J., Wang, J., Pappas, D. J., Casazza, S., Okuda, D. T., Hauser, S. L., Oksenberg, J. R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805065105 · Cited by 126
Self-citationLyons, P. A., Koukoulaki, M., Hatton, A., Doggett, K., Woffendin, H. B., Chaudhry, A., & Smith, K. G. C. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-64 · Cited by 122
Genome-wide association study of severity in multiple sclerosis
International Multiple Sclerosis Genetics Consortium, Briggs, F. B. S., Shao, X., Goldstein, B. A., Oksenberg, J. R., Barcellos, L. F., & De Jager, P. L. (2011) · Genes & Immunity · doi:10.1038/gene.2011.34 · Cited by 120
Absorption, Distribution, Metabolism and Excretion Pharmacogenomics of Drugs of Abuse
Meyer, M. R., & Maurer, H. H. (2011) · Pharmacogenomics · doi:10.2217/pgs.10.171 · Cited by 120
Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA
Cree, B., Reich, D., Khan, O. A., Jager, P. L. D., Nakashima, I., Takahashi, T., Bar‐Or, A., Tong, C., Hauser, S. L., & Oksenberg, J. R. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.541 · Cited by 117
Self-citationSardinian multiple sclerosis is associated with HLA‐DR4
Marrosu, M. G., Francesco Muntoni, A., Murru, M. R., Spinicci, G., Pischedda, M. P., Goddi, F., Cossu, P., & Pirastu, M. (1988) · Neurology · doi:10.1212/wnl.38.11.1749 · Cited by 117
Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis
Celius, E. G., Harbo, H. F., EGELAND, T., Vartdal, F., Vandvik, B., & Spurkland, A. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00389-0 · Cited by 116
Self-citationN-Glycan Processing Deficiency Promotes Spontaneous Inflammatory Demyelination and Neurodegeneration
Lee, S.-U., Grigorian, A., Pawling, J., Chen, I., Gao, G., Mozaffar, T., McKerlie, C., & Demetriou, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704839200 · Cited by 112
Comabella, M., Craig, D. W., Camiña-Tato, M., Morcillo, C., Lopez, C., Navarro, A., Rio, J., BiomarkerMS Study Group, Montalban, X., & Martin, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003490 · Cited by 105
Kofler, D. M., Severson, C., Mousissian, N., Jager, P. L. D., & Hafler, D. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100626 · Cited by 101
A genome screen for multiple sclerosis in Sardinian multiplex families
Coraddu, F., Sawcer, S. J., D’Alfonso, S., Lai, M., Hensiek, A. E., Solla, E., Broadley, S., Mancosu, C., Pugliatti, M., Marrosu, M. G., et al. (2001) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200680 · Cited by 96
HLA B*44: Protective effects in MS susceptibility and MRI outcome measures
Healy, B. C., Liguori, M., Tran, D., Chitnis, T., Glanz, B. I., Wolfish, C. S., Gauthier, S. A., Buckle, G. J., Houtchens, M. K., Stazzone, L., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ed9c9c · Cited by 96
Vartdal, F., Sollid, L. M., Vandvik, B., Markussen, G., & Thorsby, E. (1989) · Human Immunology · doi:10.1016/0198-8859(89)90074-8 · Cited by 95
Rubio, J. P., Bahlo, M., Butzkueven, H., van der Mei, I. A. F., Sale, M. M., Dickinson, J. L., Groom, P., Johnson, L., Simmons, R. D., Tait, B. D., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339932 · Cited by 94
The sociobiology of molecular systems
Foster, K. R. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2903 · Cited by 91
Ioannidis, J. P. A. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.833392 · Cited by 91
Shared genetics in coeliac disease and other immune-mediated diseases
Gutierrez‐Achury, J., de Almeida, R. C., & Wijmenga, C. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02375.x · Cited by 84
HLA Class II Susceptibility to Multiple Sclerosis Among Ashkenazi and Non-Ashkenazi Jews
Kwon, O. J., Karni, A., Israel, S., Brautbar, C., Amar, A., Meiner, Z., Abramsky, O., & Karussis, D. M. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.555 · Cited by 82
Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis
Nischwitz, S., Cepok, S., Kroner, A., Wolf, C., Knop, M., Müller-Sarnowski, F., Pfister, H., Roeske, D., Rieckmann, P., Hemmer, B., et al. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.06.003 · Cited by 79 · cited 1×
“Thus, the association of the HLA class II haplotype DRB1*15:01, DQA1*01:02, DQB1*06:02 in MS (genotypes corresponding to the serologic alleles HLA-DR2, DQ6) was then firmly established (24).”
BackgroundMicroarray analysis identifies interferon beta-regulated genes in multiple sclerosis.
Koike, F., Satoh, J., Miyake, S., Yamamoto, T., Kawai, M., Kikuchi, S., Nomura, K., Yokoyama, K., Ota, K., Kanda, T., et al. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00155-3 · Cited by 79
DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro‐Brazilians
Caballero, A., Alves‐Leon, S. V., Papais‐Alvarenga, R., Fernández, Ó., Navarro, G., & Alonso, A. (1999) · Tissue Antigens · doi:10.1034/j.1399-0039.1999.540511.x · Cited by 78
Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis
Rodríguez, J., López‐Botet, M., Munteis, E., Río, J., Roquer, J., Montalbán, X., & Comabella, M. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.09.006 · Cited by 78
Smestad, C., Brynedal, B., Jonasdottir, G., Lorentzen, Å. R., Masterman, T., Åkesson, E., Spurkland, A., Lie, B. A., Palmgren, J., Celius, E. G., et al. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01825.x · Cited by 75
Self-citationCree, B., Rioux, J. D., McCauley, J. L., Gourraud, P., Goyette, P., McElroy, J. P., Jager, P. L. D., Santaniello, A., Vyse, T. J., Gregersen, P. K., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011296 · Cited by 74
Self-citationDeterminants of interferon β efficacy in patients with multiple sclerosis
Killestein, J., & Polman, C. H. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.22 · Cited by 72
Killer immunoglobulin‐like receptor ligand HLA‐Bw4 protects against multiple sclerosis
Lorentzen, Å. R., Karlsen, T. H., Olsson, M., Smestad, C., Mero, I., Woldseth, B., Sun, J., Senitzer, D., Celius, E. G., Thorsby, E., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21695 · Cited by 71
Self-citationComputational classifiers for predicting the short-term course of Multiple sclerosis
Bejarano, B., Bianco, M., González‐Morón, D., Sepulcre, J., Goñi, J., Arcocha, J., Soto, O., Carro, U. D., Comı, G., Leocani, L., et al. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-67 · Cited by 67
Bertolotto, A., Sala, A., Malucchi, S., Marnetto, F., Caldano, M., Sapio, A. D., Capobianco, M., & Gilli, F. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.037259 · Cited by 65
Sellebjerg, F. T., Krakauer, M., Hesse, D., Ryder, L. P., Alsing, I., Jensen, P. E. H., Koch‐Henriksen, N., Svejgaard, A., & Sørensen, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02716.x · Cited by 62
Zuvich, R. L., Bush, W. S., McCauley, J. L., Beecham, A. H., Jager, P. L. D., Ivinson, A. J., Compston, A., Hafler, D. A., Hauser, S. L., Sawcer, S. J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr250 · Cited by 56
Self-citationThe HLA locus and multiple sclerosis in Sicily
Brassat, D., Salemi, G., Barcellos, L. F., McNeill, G., Proia, P., Hauser, S. L., Oksenberg, J. R., & Savettieri, G. (2005) · Neurology · doi:10.1212/01.wnl.0000149765.71212.0a · Cited by 55
Self-citationImrell, K., Greiner, E., Hillert, J. A., & Masterman, T. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.03.005 · Cited by 49
Decreased integrin gene expression in patients with MS responding to interferon-β treatment
Muraro, P. A., Liberati, L., Bonanni, L., Pantalone, A., Caporale, C. M., Iarlori, C., Luca, G. D., Farina, D., Lugaresi, A., & Gambi, D. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.01.002 · Cited by 46
Refining the association of MHC with multiple sclerosis in African Americans
McElroy, J. P., Cree, B., Caillier, S. J., Gregersen, P. K., Herbert, J., Khan, O. A., Freudenberg, J., Lee, A., Bridges, S. L., Hauser, S. L., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq197 · Cited by 43
Self-citationKaushansky, N., Altmann, D. M., David, C. S., Lassmann, H., & Ben‐Nun, A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-29 · Cited by 42
Bustamante, M. F., Fissolo, N., Río, J., Espejo, C., Costa, C., Mansilla, M. J., Lizasoaín, I., Moro, M. Á., Edo, M. C., Montalbán, X., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22511 · Cited by 40
Harbo, H. F., Utsi, E., Lorentzen, Å. R., Kampman, M. T., Celius, E. G., Myhr, K. M., Lie, B. A., Mellgren, S. I., & Thorsby, E. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00803.x · Cited by 40
Self-citationiCTNet: A Cytoscape plugin to produce and analyze integrative complex traits networks
Wang, L., Khankhanian, P., Baranzini, S. E., & Mousavi, P. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-380 · Cited by 40
Self-citationBayes factors in complex genetics
Sawcer, S. J. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.17 · Cited by 36
Spurkland, A., Celius, E. G., Knutsen, I., Belske, A., Thorsby, E., & Vartdal, F. (1997) · Tissue Antigens · doi:10.1111/j.1399-0039.1997.tb02828.x · Cited by 36
Romero-Pinel, L., Pujal, J. M., Martínez‐Yélamos, S., Gubieras, L., Matas, E., Bau, L., Torrabadella, M., Azqueta, C., & Arbizu, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03148.x · Cited by 33
Gourraud, P. (2011) · Genetic Epidemiology · doi:10.1002/gepi.20592 · Cited by 22
Self-citationBabron, M., Perdry, H., Handel, A. E., Ramagopalan, S. V., Damotte, V., Fontaine, B., Müller‐Myhsok, B., Ebers, G. C., & Clerget‐Darpoux, F. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.197 · Cited by 21
Interferon-beta responders and non-responders. A biological approach
Bertolotto, A., & Gilli, F. (2008) · Neurological Sciences · doi:10.1007/s10072-008-0941-2 · Cited by 20
Baranzini, S. E. (2006) · Autoimmunity · doi:10.1080/08916930601061686 · Cited by 18
Self-citationNorwegian Sami differs significantly from other Norwegians according to their HLA profile
Harbo, H. F., Riccio, M. E., Lorentzen, Å. R., Utsi, E., Myhr, K., Mellgren, S. I., Flåm, S. T., Thorsby, E., Sanchez‐Mazas, A., & Lie, B. A. (2009) · Tissue Antigens · doi:10.1111/j.1399-0039.2009.01425.x · Cited by 18
Self-citationGilli, F. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0098 · Cited by 15
Bergamaschi, L., Ban, M., Barizzone, N., Leone, M. A., Ferrante, D., Fasano, M. E., Guerini, F. R., Corrado, L., Naldi, P., Dametto, E., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.080721 · Cited by 15
Khan (2000) · doi:10.1002/1531-8249(200008)48:2
Cited by
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium, Patsopoulos, N. A., Baranzini, S. E., Santaniello, A., Shoostari, P., Cotsapas, C., Wong, G., Beecham, A. H., James, T., Replogle, J., et al. (2019) · Science · doi:10.1126/science.aav7188 · Cited by 1,818
“Although the exact amount of MS’s heritability varies given the data and method used, (36-38) we report that our findings can explain up to 48% of the heritability that can be estimated using large-scale GWAS data.”
MethodSelf-citationAnalysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International Multiple Sclerosis Genetics Consortium (IMSGC) (2013) · Nature Genetics · doi:10.1038/ng.2770 · Cited by 1,386
“Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.”
Pathological mechanisms in progressive multiple sclerosis
Mahad, D. H., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,137
Multiple Sclerosis: Current Knowledge and Future Outlook
Kamm, C. P., Uitdehaag, B. M., & Polman, C. H. (2014) · European Neurology · doi:10.1159/000360528 · Cited by 1,010
Sex and gender issues in multiple sclerosis
Harbo, H. F., Gold, R., & Tintoré, M. (2013) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613488434 · Cited by 529
Self-citation
Metadata
- Authors
- Gourraud, P., Harbo, H. F., Hauser, S. L., & Baranzini, S. E.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2012-06-21
- Volume
- 248
- Issue
- 1
- Pages
- 87-103
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2137277521
- Cited by
- 282
- References
- 121
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.